NEW YORK, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will present at the Emerging Growth Conference on December 7, 2023. The Company will provide insight into the Company’s unique proprietary Intelligent Fingerprinting Drug Screening System, among other topics.
Harry Simeonidis, INBS’ President and Chief Executive Officer, is scheduled to present from 2:20 p.m. to 2:50 p.m. Eastern Time on Thursday, December 7, 2023.
Link to register: https://goto.webcasts.com/starthere.jsp?ei=1641026&tp_key=4a8f04de2b&sti=vtak
Following the event, an archived webcast will be available on emerginggrowth.com and the Emerging Growth YouTube Channel: https://www.YouTube.com/EmergingGrowthConference. A link to the webcast will be released after the event for convenient access.
Attendees are encouraged to submit their questions in advance to Questions@EmergingGrowth.com or ask questions throughout the event.
https://www.globenewswire.com/news-release/2023/11/29/2787750/0/en/Intelligent-Bio-Solutions-Inc-to-Present-at-the-Emerging-Growth-Conference-on-December-7-2023.html